Ninety percent of prescription drugs don't work about 50% of the time.1 But, more effective, more personalized medicine is becoming possible as the cost of decoding human DNA drops -- from $3 billion in 1993 to a few thousand dollars today.
Doctors will be able to predict the diseases you're likely to get long before they appear in lab tests and prescribe treatments tailored specifically to work based on your genetic make-up.
Pharmaceutical companies have already begun switching from mass-production to developing drugs custom-made to work for specific genetic profiles, a change that could transform their approach to everything from cancer and depression to heart disease and Alzheimer's.
Technology start-ups and insurance giants are creating tools that add genetic data to electronic medical records, making it possible for patients to shop for providers with the best results treating patients like them.
Because medical spending accounts for almost 20% of U.S. consumer spending,2 this new, more patient-centric system could save the health care industry billions of dollars a year and create huge new investing opportunities throughout the economy.
Meet the analyst
Edward L. Yoon
Edward (“Eddie”) Yoon is a research analyst for Fidelity Asset Management. Fidelity Investments is a leading provider of investment management, retirement planning, portfolio guidance, brokerage, benefits outsourcing and other financial products and services to more than 20 million individuals, institutions and financial intermediaries. Mr. Yoon is responsible for coverage of health care equipment and supplies stocks and serves as the health care sector leader for Fidelity Asset Management.
Prior to joining Fidelity in July 2006, Mr. Yoon was an analyst for JP Morgan Asset Management from 2002 until 2006 and a co-fund manager for the firm from 2005 until 2006.
Born in 1980, Mr. Yoon received a bachelor of arts degree in business economics from Brown University in 2002.
"A Drug Of Your Own"
"The microeconomics of personalized medicine"
New England Journal of Medicine
"The Path to Personalized Medicine"
New York Times
"Study Says DNA’s Power to Predict Illness Is Limited"
Wall Street Journal
"A Doctor in Your Pocket"
The Language of Life: DNA and the Revolution in Personalized Medicine
by Francis S. Collins
The Quest for the Cure: The Science and Stories Behind the Next Generation of Medicines
by Brent R. Stockwell